ARCBEST CORP (ARCB)       91.98  +0.68 (+0.74%)

91.98  +0.68 (+0.74%)

US03937C1053 - Common Stock - After market: 91 -0.98 (-1.07%)


Fundamental Rating

Taking everything into account, ARCB scores 7 out of 10 in our fundamental rating. ARCB was compared to 47 industry peers in the Road & Rail industry. ARCB scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ARCB is valued quite cheap, while showing a decent growth score. This is a good combination! This could make ARCB a good candidate for value investing.




Profitability

Profitability Rating


ARCB has a Return On Assets of 13.13%. This is amongst the best returns in the industry. The industry average is 7.72%. ARCB outperforms 91% of its industry peers.
ARCB has a Return On Equity of 28.33%. This is better than the industry average of 24.37%.

The Piotroski-F score of ARCB is 8.00. This is a very strong score and indicates great health and profitability for ARCB.
ARCB's Profit Margin of 6.11% is in line with the rest of the industry. The industry average Profit Margin is 6.71%.
VS Industry

ROA (13.13%) VS Industry: 91% outperformed.

-395.56
25.89

ROE (28.33%) VS Industry: 67% outperformed.

1.32
62.70

Profit Margin (6.11%) VS Industry: 47% outperformed.

-6,060.10
33.30

Valuation

Valuation Rating


With a Price/Earnings Ratio of 7.21, the valuation of ARCB can be described as very cheap.
ARCB's Price/Earning Ratio is rather cheap when compared to the industry average which is at 14.64. ARCB is also cheaper than 85% of the companies in the same industry.
The Forward Price/Earnings Ratio of 7.56 indicates a rather cheap valuation of ARCB.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

When comparing the Enterprise Value to EBITDA ratio of ARCB to the average industry ratio of 7.44, ARCB is valued rather cheaply. ARCB is also cheaper than 91% of the companies listed in the same industry.
When comparing the current price to the book value of ARCB, we can conclude it is valued correctly. It is trading at 2.12 times its book value.
When comparing the price book ratio of ARCB to the average industry price book ratio of 2.77, ARCB is valued in line with its industry peers.
VS Industry

Price/Earnings (7.21) VS Industry: 85% outperformed.

118.18
4.43

Price/Book (2.12) VS Industry: 58% outperformed.

22.06
0.30

Enterprise Value/ EBITDA (4.2) VS Industry: 91% outperformed.

64.80
0.26

Growth

Growth Rating


The Earnings Per Share has grown by an impressive 146.81% over the past year.
The Earnings Per Share has been growing by 55.48% on average over the past 5 years. This is a very strong growth
The Revenue has grown by 45.44% in the past year. This is a very strong growth!
The Earnings Per Share is expected to grow by 3.09% on average over the next 5 years.

ARCB shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 8.07% yearly.
ARCB is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 7.46% yearly.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS55.48% 29.38% 146.81% 66.8% 20.68% 12.02% 3.09%
Revenue8.07% 8.76% 45.44% 39.52% 18.81% 12.61% 7.46%

Health

Health Rating


With a Debt to Equity ratio of 0.16, ARCB is doing better than the averages in the industry. The industry average is at 0.55.
An Altman-Z score of 4.51 indicates that ARCB is not in any danger for bankruptcy at the moment.
When comparing the Altman-Z score to an average industry score of 2.83, ARCB is in better financial health than the average industry peer.
The Piotroski-F score of ARCB is 8.00. This is a very strong score and indicates great health and profitability for ARCB.

ARCB has a Current Ratio of 1.25. This is a normal value and indicates that ARCB is financially healthy and should not expect problems in meeting its short term obligations.
The Current Ratio is in line with the industry averages, which is at 1.18.
A Quick Ratio of 1.25 indicates that ARCB should not have too much problems paying its short term obligations.
ARCB has a Quick Ratio comparable to the industry average, which is at 1.15.
VS Industry

Debt/Equity (0.16) VS Industry: 68% outperformed.

5.20
0.00

Quick Ratio (1.25) VS Industry: 59% outperformed.

0.24
29.75

Current Ratio (1.25) VS Industry: 59% outperformed.

0.24
29.75

Altman-Z (4.51) VS Industry: 78% outperformed.

-13.40
20.53

Dividend

Dividend Rating


ARCB pays out 2.98% of its income as dividend. This is a sustainable payout ratio.
ARCB has paid a dividend for at least 10 years, which is a reliable track record.
ARCB has a yearly dividend return of 0.59%, which is pretty low.

With a Dividend Yield of 0.59, ARCB pays less dividend than the industry average, which is at 1.26. 92% of the companies listed in the same industry pay a better dividend than ARCB!
With a Dividend Yield of 0.59, ARCB pays less dividend than the S&P500 average, which is at 2.39.
VS Industry

Dividend Yield (0.59%) VS Industry: 8% outperformed.

0.43
5.16
ARCB Daily chart

ARCBEST CORP91.98

NASDAQ:ARCB (8/16/2022, 7:16:51 PM)+0.68 (+0.74%)

After market: 91 -0.98 (-1.07%)

Chartmill FA Rating
GICS Sector Industrials
GICS IndustryGroup Transportation
GICS Industry Road & Rail
Earnings (Last) 07-29 2022-07-29/bmo Earnings (Next) 10-31 2022-10-31
Ins Owners 2.43% Inst Owners 87.2%
Market Cap 2.25B Analysts 80
Valuation
PE 7.21 Fwd PE 7.56
PEG (NY) 0.11 PEG (5Y) 0.13
P/S 0.46 P/B 2.12
EV/EBITDA 4.2
Profitability
ROA 13.13% ROE 28.33%
PM 6.11 Asset Turnover 2.15
Growth
EPS 1Y 146.81% EPS 3Y 29.38%
EPS 5Y 55.48% EPS growth Q2Q 118.27%
EPS Next Y 66.8% EPS Next 2Y 20.68%
EPS Next 3Y 12.02% EPS Next 5Y 3.09%
Revenue growth 1Y 45.44% Revenue growth 3Y 8.76%
Revenue growth 5Y 8.07% Revenue growth Q2Q 46.78%
Revenue Next Year 39.52% Revenue Next 2Y 18.81%
Revenue Next 3Y 12.61% Revenue Next 5Y 7.46%
Health
Current Ratio 1.25 Quick Ratio 1.25
Altman-Z 4.51 F-Score 8
Debt/Equity 0.16
Dividend
Dividend Yield 0.59% Dividend Growth N/A
DP 2.98% Ex-Date 08-09 2022-08-09 (0.12)

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA